China High Speed Transmission Equipment Group Commences Legal Proceedings for Fund Misappropriation of RMB 6.64 Billion

China High Speed Transmission Equipment Group Commences Legal Proceedings for Fund Misappropriation of RMB 6.64 Billion

HONG KONG, April 1, 2025 /PRNewswire/ -- The Board of Directors (the "Board") of China High Speed Transmission Equipment Group Co., Ltd. (the "Company", Stock Code: 0658.HK, together with its subsidiaries, the "Group") today announced that its...

Recon Technology, Ltd Reports Financial Results for the First Six Months of Fiscal Year 2025

Recon Technology, Ltd Reports Financial Results for the First Six Months of Fiscal Year 2025

BEIJING, April 1, 2025 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company"), a China-based independent solutions integrator in the oilfield service and environmental protection, electric power and coal chemical industries,...

Eoptolink Demonstrates 1.6T LRO Modules at OFC 2025

Eoptolink Demonstrates 1.6T LRO Modules at OFC 2025

SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, is demonstrating its 1.6T LRO transceiver operating at 212Gb/s per lambda...

Eoptolink Unveils Industry-First 800G Optical Transceiver for Multicore Fiber at OFC 2025

Eoptolink Unveils Industry-First 800G Optical Transceiver for Multicore Fiber at OFC 2025

SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, is demonstrating industry's first 800G optical transceiver supporting Multicore...

Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia

Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a...

SF Holding Delivered Record High 2024 Financial Results

SF Holding Delivered Record High 2024 Financial Results

Record-high annual revenue: RMB284.4 billion, up 10.1% year-over-year Record-high annual net profit attributable to owners of the company: RMB10.2 billion, up 23.5% year-over-year Delivered total shareholder return of RMB10.7 billion SHENZHEN,...

Coway Holds 36th Annual General Meeting to Further Strengthen Shareholder Trust Through Sustainable Growth

Coway Holds 36th Annual General Meeting to Further Strengthen Shareholder Trust Through Sustainable Growth

Shareholders have rejected Align Partners' proposal for a cumulative voting system, reaffirming board independence Key agenda items, including the appointment of outside directors and the retirement of 650,000 treasury stocks to enhance shareholder...

Africa's largest optical fibre cable manufacturing facility is set to become a skills hub of excellence in optical fibre

Africa's largest optical fibre cable manufacturing facility is set to become a skills hub of excellence in optical fibre

DURBAN, South Africa, March 31, 2025 /PRNewswire/ -- Recently, Yangtze Optics Africa Cable (Pty) Ltd (YOA Cable) solidified its position as the largest optical fibre manufacturer in Africa following a significant expansion investment of optical...

Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024

Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024

XI'AN, China, March 31, 2025 /PRNewswire/ -- Entrepreneur Universe Bright Group ("EUBG" or the "Company"), a Nevada corporation, today announced its audited financial results for the fiscal year ended December 31, 2024. The Company reported total...

AIM Vaccine reduces losses by nearly 90% in 2024, with the iterative major product series opening up space for explosive growth in performance

AIM Vaccine reduces losses by nearly 90% in 2024, with the iterative major product series opening up space for explosive growth in performance

HONG KONG, March 31, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an increase of...

  • 1
  • ...
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • ...
  • 72
  • menu
    menu